Laurus Labs Limited (NSE:LAURUSLABS)
India · Delayed Price · Currency is INR 986.15
+35.60 (3.75%)
Feb 9, 2026, 3:30 PM IST
Laurus Labs Market Cap
Laurus Labs has a market cap or net worth of 532.03 billion as of February 9, 2026. Its market cap has increased by 68.87% in one year.
Market Cap
532.03B
Enterprise Value
554.79B
Revenue
67.22B
Ranking
n/a
PE Ratio
63.13
Stock Price
986.15
Market Cap Chart
Since December 19, 2016, Laurus Labs's market cap has increased from 47.44B to 532.03B, an increase of 1,021.52%. That is a compound annual growth rate of 30.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 513.16B | -14.21% |
| Dec 31, 2025 | 598.16B | 84.05% |
| Dec 31, 2024 | 325.01B | 40.17% |
| Dec 29, 2023 | 231.86B | 14.74% |
| Dec 30, 2022 | 202.07B | -30.12% |
| Dec 31, 2021 | 289.18B | 52.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cipla | 1.08T |
| Zydus Lifesciences | 893.69B |
| Mankind Pharma | 850.46B |
| Aurobindo Pharma | 691.73B |
| Alkem Laboratories | 679.61B |
| Glenmark Pharmaceuticals | 546.00B |
| Ipca Laboratories | 365.89B |
| Ajanta Pharma | 351.85B |